Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Thioglycollate (mercaptoacetate) is a sulfur-containing organic anion primarily used in the form of its salts, such as calcium, potassium, or sodium thioglycollate. In pharmaceutical and cosmetic applications, it serves as a depilatory agent by reducing the disulfide bonds in hair keratin, which weakens the hair shaft and facilitates its removal. In laboratory settings, sodium thioglycollate is a key component of anaerobic culture media (e.g., thioglycollate broth), where it acts as a reducing agent to maintain low oxygen tension. In immunological research, it is frequently used to induce sterile peritonitis in animal models to study macrophage recruitment and activation. It is important to note that in some clinical trial documentation translated from Chinese, "thioglycollate" (硫糖铝) has appeared as an erroneous translation for **sucralfate** (an aluminum sucrose sulfate complex); consequently, trials involving "thioglycollate gel" for esophageal mucosal protection are likely investigating sucralfate rather than thioglycollate.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on thioglycollate.